Articles
Mechanisms of Action
In-depth, citation-backed writing on mechanisms of action. · 3 articles in Mechanisms of Action
How Does Semaglutide Engage Hypothalamic Hunger Circuitry in Humans, and What Does the 2026 AgRP Neuron Evidence Mean for Dosing and Response Prediction?
Semaglutide suppresses appetite primarily by activating GLP-1 receptors in the hypothalamic arcuate nucleus and brainstem, but a 2026 Yale/PNAS study overturned the prevailing model: rather than silencing hunger-promoting AgRP neurons, semaglutide recruits them as required effectors of sustained weight loss. This reframing has direct implications for dose-escalation strategy and for predicting which patients will respond.
What Does the 2026 Rat Study Reveal About Semaglutide-Induced Prolonged GLP-1 Receptor Activation and Sodium Balance?
A 2026 study published in the Journal of Evolutionary Biochemistry and Physiology demonstrated for the first time that semaglutide — administered at doses of 0.125–8 nmol per 100 g body weight in rats — produces dose-dependent natriuresis through prolonged glucagon-like peptide-1 receptor (GLP-1R) activation, establishing a direct mechanistic link between sustained GLP-1R occupancy and renal sodium handling.
Why Do GIP Receptor Agonists and Antagonists Both Produce Weight Loss in 2026 Obesity Trials?
Both GIP receptor (GIPR) agonism and antagonism reduce body weight in preclinical and early clinical models, a paradox explained by tissue-specific receptor desensitisation, differential central versus peripheral signalling, and the obligate co-presence of GLP-1 receptor activity in every trial where antagonism has shown efficacy. Neither pharmacological direction acts on GIPR in isolation.